|
|
|
Scleroderma is an autoimmune connective tissue disorder with symptoms ranging from mild localized lesions to a systemic disease injuring multiple organs.
Scleroderma, which is also called systemic sclerosis, is a chronic autoimmune connective tissue disorder in which normal tissue is replaced with thick, hardened, fibrous tissue. Fibrous tissue, which resembles scar tissue, is caused by increased production of the protein collagen. Scleroderma primarily affects the skin, but it can also affect other tissues and organs. Who is Affected?In the U.S. scleroderma is rare, affecting only 200-300 of each one million persons. Each year 12-13 cases for each million people are diagnosed. About 75 percent of patients are females, and most people are diagnosed between the ages of 30 and 50 years. People of all ages, including children, may be affected although the disease course may be different in children. Types of SclerodermaThere are two major types or forms of scleroderma:
Subtypes of Systemic SclerodermaSystemic scleroderma may be diffuse or limited. Patients with both scleroderma and the autoimmune liver disease primary biliary cirrhosis have Reynold's syndrome.
CausesScleroderma develops in people with certain genes who are exposed to certain environmental triggers. Scleroderma can occur in families, and patients with scleroderma often have a family history of scleroderma or other autoimmune diseases. The Choctaw Native Americans have the highest reported prevalence of scleroderma. Environmental triggers suspected of inducing scleroderma include repetitive motion, vibrational tasks, silica dust, recreational drugs and industrial solvents. Scleroderma-like conditions have been caused by contaminated rapeseed oil, polyvinylchloride, and contaminated tryptophan. However, most people with scleroderma do not have any connection to these environmental triggers. DiagnosisScleroderma is diagnosed on the basic of physical findings, imaging tests and laboratory tests. Patients with scleroderma usually have positive ANA tests with patterns suggestive of scleroderma. Tests for scl70 antibodies help differentiate the type of scleroderma present. TreatmentThere are no treatments available to cure scleroderma. However, a variety of immunosuppressive medications such as methotrexate can reduce disease progression and ameliorate specific symptoms such as pain. In addition, vasodilators including calcium channel blockers can reduce symptoms associated with Raynaud’s phenomenon. It’s important to keep the skin well lubricated and protected from the elements. Digital injury should be avoided by using appropriate protection during activities. Exercise is important in maintaining joint mobility and muscle tone. A nutrient-rich diet is important for immune system health, and frequent small meals with food that is easy to chew benefit patients who have gastrointestinal involvement. The recommendations for dietary supplements and for diet and lifestyle in Lupus are also beneficial for patients with scleroderma. Resources: Elaine Moore, Autoimmune Diseases and Their Environmental Triggers, Jefferson, NC: McFarland Publishing, 2002. What You Need to Know About Scleroderma, Rheumatic and Immunologic Diseases, Cleveland Clinic, accessed April 1, 2007. Scleroderma (Systemic Sclerosis), American College of Rheumatology, accessed April 1, 2007
The copyright of the article Understanding Scleroderma in Autoimmune Disease is owned by Elaine Moore. Permission to republish Understanding Scleroderma in print or online must be granted by the author in writing.
|
|
|
|
|
|
|
|